240 likes | 257 Views
Discover the latest developments in treating metastatic colorectal cancer (mCRC) and explore emerging questions. Delve into potential replacements for 5-FU like Xeloda, strategic utilization of effective agents, and optimal combinations of anti-angiogenics with cytotoxics. Dive into the impact of drug holidays on chemotherapy tolerance and efficacy.
E N D